Tachykinin actions are mediated by at least three distinct receptors designated as NK
1, NK
2 and NK
3. The endogeneous tachykinin ligands interact with all tachykinin receptors, although there is a defined agonist rank order of potency such that substance P (SP), neurokinin A (NKA), and neu-rokinin B (NKB) have the highest affinities for the NK
1, NK
2 and NK
3 receptors, respectively. SP, NKA, and NKB have all been linked to numerous chronic diseases, including asthma and chronic obstructive pulmonary disease. Speculating that a combined tachykinin receptor antagonist may be of greater benefit than a selective antagonist in the treatment of pulmonary diseases, we designed a series of novel morpholine and oxazolidine analogues (I and II). We report herein the synthesis and structure-activity relationships of novel morpholine- and oxazolidine-based ana-logues with regards to NK
1, NK
2 and NK
3 tachykinin receptor binding affinity. Efficient and practi-cal synthetic methods for the preparation of enantiomerically pure 2- [(2
R) -arylmorpholin-2-yl] ethanols 8a-d and 2- [(5
R) -aryloxazolidin-5-yl] ethanols 23a-d, key intermediates of I and II are described. Among these analogues, the compounds that possess properties such as spiro [benzo [
c] thiophene-1 (3
H), 4'-piperidine] - (2
S) -oxide (
S) -29 and spiro [((2S) -hydroxy) indane-1, 4'-piperidine] (
S) -41 moiety had strong binding affinities to the tachykinin receptor. This report also describes efficient and practical synthetic methods for the preparation of enan-tiomerically pure (
S) -29 and (
S) -41. One of the enantiomers, (
S,
R) -42 HCl salt (R-113281), exhib-ited high binding affinities for NK
1, NK
2 and NK
3 receptors in humans and guinea pigs. In vivo, R-113281 exerted highly potent antagonism toward SP-induced tracheal vascular hyperpermeabili-ty and NKA-, NKB- and capsaicin-induced bronchoconstriction in guinea pigs.
抄録全体を表示